-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
Author: Sunshine
August 26, clinical trials show default permission CDE official website, CTTQ clinical trial application TQA3605 piece obtained SFDA, alone or in combination with nucleoside (acid) treatment of chronic hepatitis
Chronic hepatitis B is a chronic disease in which hepatitis B virus (HBV) is continuously infected for more than 6 months, and the liver undergoes varying degrees of inflammatory necrosis (or) fibrosis
China is a big country for hepatitis B.
After the hepatitis B virus enters the host, it will integrate its genome into the NDA in the nucleus of the host's liver cells to form a covalently closed circular DNA (cccDNA), and then use the host to synthesize mRNA and the protein required for viral particle assembly
Note: The original text has been deleted